Michael Law

Mike

Faculty, Centre for Health Services and Policy Research
Canada Research Chair in Access to Medicines
Associate Professor, UBC School of Population and Public Health

michael.law@ubc.ca
@MikeLawUBC
(604) 822-3514


Profile

Dr. Michael Law holds the Canada Research Chair in Access to Medicines, and is an Associate Professor in the Centre for Health Services and Policy Research, School of Population and Public Health, at the University of British Columbia.

Michael’s research program focuses on pharmaceutical policy. His work focuses on access to and the use of prescription drugs, including the affordability of prescription drugs, private drug insurance, generic drug pricing, and the impact of pharmacist prescribing. His research program has attracted more than $2.5 million in research funding, including 4 operating grants from CIHR as principal investigator.

He has been published in leading medical journals, including BMJ, Archives of Internal Medicine, and CMAJ. This work has been featured in news media such as New Scientist, Forbes, the Globe & Mail, and USA Today. He has also authored commentaries that have appeared in the Toronto Star and Vancouver Sun. His research has had a major impact on generic drug pricing in Canada, leading to policy changes that have saved governments the country more than $100 million every year.

Since his appointment at UBC he has received several notable awards, including a Distinguished Achievement Award from the UBC Faculty of Medicine (2012), the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the Canadian Institute for Health Services and Policy Research, a Canadian Institutes of Health Research New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.

In 2015, he taught one of UBC’s first edX.org Professional Education courses on Interrupted Time Series Analysis.

Prior to joining UBC, he completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. He has also completed an MSc from the London School of Economics, and worked as a research associate at the University of Auckland, New Zealand.

Education

PhD, Health Policy, Harvard University, 2008
MSc, Health Population and Society, London School of Economics, 2002
BA&Sc, Arts & Sciences Program, McMaster University, 2001

Research Interests

  • Pharmaceutical policy
  • Direct-to-consumer advertising of prescription drugs
  • Medication adherence and health outcomes

Current Projects

  • Cost-related nonadherence to prescription drugs: A multi-method study
  • Impact of physician detailing and sampling for generic atorvastatin

Affiliations and Awards

  • Career Investigator Scholar Award, Michael Smith Foundation for Health Research, 2012-2020
  • New Investigator Award, CIHR, 2010-2015

Current Graduate Students

  • Rachel McKay, PhD Student, School of Population and Public Health
  • Fiona Chan, MSc Student, School of Population and Public Health
  • Celestin Hategekimana, PhD Student, School of Population and Public Health
  • Harriet Ho, MSc Student, School of Population and Public Health
  • Hinda Ruton, PhD Student, School of Population and Public Health

Currently Recruiting Graduate Students Interested in

  • Pharmaceutical policy
  • Access to medicines
  • Observational study design

Courses Currently Taught


Recent Publications

Skeldon SC, Macdonald EM, Law MR, Huang A, Paterson JM, Mamdani MM, Juurlink D. The Cardiovascular Safety of Dutasteride. J Urol. 2016 Nov 16. [Epub ahead of print] Read more

Innes GD, Scheuermeyer FX, Law MR, McRae AD, Weber BA, Boyda HN, Lonergan K, Andruchow JE. Sex-related Differences in Emergency Department Renal Colic Management: Females Have Fewer Computed Tomography Scans but Similar Outcomes. Acad Emerg Med. 2016 Oct;23(10):1153-1160. Read more

Kolhatkar A, Cheng L, Chan F, Harrison M, Law M. The impact of medication reviews by community pharmacists. Journal of the American Pharmacists Association 2016:56(5):513-20. Read more

Panagiotoglou D, Law MR, McGrail K. Effect of Hospital Closures on Acute Care Outcomes in British Columbia, Canada: An Interrupted Time Series Study. Med Care. 2016 Aug 19. [Epub ahead of print] Read more

Lavergne MR, Law MR, Peterson S, Garrison S, Hurley J, Cheng L, McGrail K. A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease. CMAJ. 2016 Aug 15. [Epub ahead of print] Read more

McKay R, Mah A, Law M, McGrail K, Patrick DM. Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections. Antimicrob Agents Chemother. 2016 May 2. [Epub ahead of print] Read more

Lavergne MR, Barer M, Law MR, Wong ST, Peterson S, McGrail K. Examining regional variation in health care spending in British Columbia, Canada. Health Policy. 2016 Apr 20. [Epub ahead of print] Read more

Worthington H, Law M. Sticker Shock: Finding value in an era of high-cost drugs: Conference Summary. Vancouver (BC): UBC Centre for Health Services and Policy Research; 2015. Read more

Skeldon SC, Detsky AS, Goldenberg SL, Law MR. Erectile Dysfunction and Undiagnosed Diabetes, Hypertension, and Hypercholesterolemia. Ann Fam Med. 2015 Jul-Aug;13(4):331-5. Read more

Law MR, Cheng L, Kratzer J, Morgan SG, Marra C, Lynd LD, Majumdar SR. Impact of allowing pharmacists to independently renew prescriptions: A population-based study. J Am Pharm Assoc (2003). 2015 Jul 1;55(4):398-404. Read more

Kratzer J, Cheng L, Allin S, Law MR. The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada. Healthc Policy. 2015 May;10(4):62-74. Read more

Skeldon SC, Kozhimannil KB, Majumdar SR, Law MR. The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis. J Gen Intern Med. 2015 Apr;30(4):514-20.  Read more

Gomes T, Martins D, Cheng L, Kratzer J, Juurlink DN, Shah BR, Mamdani MM, Paterson JM, Law MR. The impact of policies to reduce blood glucose test strip utilization and costs in Canada. Can J Public Health. 2015 Apr 30;106(4):e210-6. Read more

Morgan SG, Law M, Daw JR, Abraham L, Martin D. Estimated cost of universal public coverage of prescription drugs in Canada. CMAJ. 2015 Apr 21;187(7):491-7. Read more

Law MR, Kratzer J, Cheng L, Donovan S. Utilization patterns and reimbursement options for diabetes test strips in British Columbia. Vancouver (BC): UBC Centre for Health Services and Policy Research; June 2014. Read more

Older publications